DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Conditions: Breast Cancer; Breast Cancer Female; Metastatic Triple-Negative Breast Carcinoma; ER Positive Breast Cancer; HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma; ER-negative Breast Cancer Interventions: Drug: Datopotamab Deruxtecan Sponsors: Sarah Sammons, MD; Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | HER2 | Neurology | Research